666 



If you need to have our staffs meet about that, we will certainly 

 make our staff available. But we would like a commitment from 

 you to get that. 



Mr. Campbell. I hear your request. I'll have to take it — I'll make 

 the commitment to look into it and to put the two staffs together. 

 I don't know if there are any privileged documents involved. I'm 

 not sure. 



Mr. Waxman. You're the Chief Executive Officer. For what rea- 

 son could you not give us this research if it's been conducted? 



Mr. Campbell. I have no problem giving you any material we 

 have if it's not in some way involved in active litigation at this 

 time. 



Mr. Waxman. Let me tell you that litigation is not a reason not 

 to give the Congress of the United States information. We expect 

 to get it. Mr. Synar? 



Mr. Synar. Let me reiterate that there is absolutely no legal rea- 

 son why you should not be required to provide that information. 

 Your lawyers know that proprietary information provided to Con- 

 gress does not make it public. It would be handled in a confidential 

 manner. 



Gentlemen, I'm a little bit distressed as I hear some of your an- 

 swers with respect to your flippant attitude on the impact of nico- 

 tine and its addictiveness and the impact of cigarettes in general. 



I call to your attention to your left, that stack of books, over- 

 whelming medical evidence, over the last 25 years of the 

 addictiveness, as well as the hazard of the product that you 

 produce. 



Mr. Campbell, 2 weeks ago, Congressman Waxman released a 

 study written by Dr. Victor DeNoble. I'd ask unanimous consent to 

 enter in the record at this time Exhibit 5-A. 



Mr. Waxman. Without objection, that will be the order. 



Mr. Synar. As you know. Dr. DeNoble was a research scientist 

 at Philip Morris during the early 1980's. You have in front of you 

 the DeNoble study. Dr. DeNoble was studying the nicotine of rats. 

 In 1983, he found that rats will self-administer nicotine when 

 hooked up to an intravenous nicotine solution. In other words, they 

 will work to get nicotine. And as Dr. Kessler told us in the hearing 

 in which he testified, self-administration of this type is hallmark 

 addiction. 



I'd ask unanimous consent to enter in the record Exhibit 6. 



Mr. Waxman. Without objection, that will be the order. 



Mr. Synar, Mr. Campbell, before you is a press release, your 

 press release that said that Dr. DeNoble's study showed exactly the 

 opposite. I have a copy here, which is marked, and it says that the 

 DeNoble study showed that nicotine is "in a class of non-addictive 

 chemical compounds, such as saccharine or water." 



I don't think any of us are ever going to find, Mr. Campbell, a 

 study that shows rats or any other animals will self-administer sac- 

 charine or water intravenously the way they do nicotine. 



I ask unanimous consent to enter in the record Exhibit 7. 



Mr. Waxman. Without objection, that will be the order. 



Mr. Synar. Mr. Campbell, this is a letter from the Director of the 

 National Institute of Drug Abuse regarding the DeNoble study 

 which is in question here. This letter directly contradicts your as- 



